Prospective Review of 30-Day Morbidity and Mortality Following Surgery for Brain Tumors in Children

A new study has shed light on the 30-day and inpatient morbidity and mortality in pediatric patients undergoing neurosurgery for brain tumors in a tertiary neurosciences centre. The research, conducted over a 10-year period, aimed to establish the frequency of significant adverse events and review the current published rates of morbidity in this patient group. The findings highlight the importance of prospective, continuous surveillance in promoting improvement in the neurosurgical care delivered to children with brain tumors.

Key Takeaways:

• The study aimed to record the 30-day and inpatient morbidity and mortality in 209 pediatric patients undergoing neurosurgery for brain tumors over a 10-year period at a tertiary neurosciences centre in Glasgow, United Kingdom.
• A total of 285 procedures were performed, with each adverse event categorized, allocated a clinical impact severity score, and linked to a neurosurgical procedure wherever possible.
• The research established the frequency of significant adverse events and reviewed the current published rates of morbidity in this patient group, concluding that prospective, continuous surveillance promotes improvement in neurosurgical care.
• The study was conducted by a team of researchers from the Department of Pediatric Neurosurgery at the Royal Hospital for Children, including E. Campbell, L. Todd, A. Amato-Watkins, R. O'Kane, M. Sangra, and M. Canty.
• The study's findings were published in the journal Child's Nervous System, Volume 41, Issue 1, 2025, with the article titled "Prospective review of 30-day morbidity and mortality following surgery for brain tumours in children."
• The study's results have implications for improving neurosurgical care in pediatric patients with brain tumors, highlighting the need for continued surveillance and improvement in clinical management.

Statistics:

• A total of 209 patients underwent 285 neurosurgical procedures over a 10-year period.
• Each adverse event was categorized and allocated a clinical impact severity score, with the majority of events occurring within 30 days of admission.
• The study concluded that prospective, continuous surveillance promotes improvement in neurosurgical care, with implications for improving patient outcomes.
• The study's results were published in the journal Child's Nervous System, with a publication date of 2025 and Volume 41, Issue 1, Pages 162.

Sources:

• "Prospective review of 30-day morbidity and mortality following surgery for brain tumours in children." Child's Nervous System, vol. 41, no. 1, 2025, pp. 162.
• E. Campbell et al. "Prospective review of 30-day morbidity and mortality following surgery for brain tumours in children." Child's Nervous System, vol. 41, no. 1, 2025, pp. 162.
• Springer. "Child's Nervous System." Springer, 2025.